Semi‐Mechanistic Population Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Dupilumab on Pre‐Bronchodilator Forced Expiratory Volume in 1 Second (FEV1) in Uncontrolled Moderate‐To‐Severe Asthma
ABSTRACT In this study, we investigated the pharmacokinetic/pharmacodynamic (PK/PD) relationship of dupilumab as an add‐on therapy in the intent‐to‐treat (ITT) uncontrolled moderate‐to‐severe asthma population and identified the factors significantly contributing to variability in forced expiratory...
Saved in:
| Main Authors: | Li Zhang, John D. Davis, Vanaja Kanamaluru, Christine Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | CPT: Pharmacometrics & Systems Pharmacology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/psp4.70057 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of predicted postoperative forced expiratory volume in the first second (FEV1) using lung perfusion scintigraphy with observed forced expiratory volume in the first second (FEV1) post lung resection
by: Boon Mathew, et al.
Published: (2020-04-01) -
Successful treatment of scleromyxedema with dupilumab: A case report
by: Abdulelah Alghamdi, MBBS, et al.
Published: (2025-09-01) -
Dupilumab and atopic march; Reduction of incident allergic events or Clinical control?
by: Jorge Sánchez, et al.
Published: (2024-12-01) -
Efficacy of Dupilumab in the Treatment of Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
by: Szu-Hung Chu, et al.
Published: (2025-02-01) -
Population Pharmacokinetic-Pharmacodynamic (popPK/PD) Relationship of Orismilast, A Potent and Selective PDE4B/D Inhibitor, in Atopic Dermatitis
by: Richard B. Warren, et al.
Published: (2025-03-01)